Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose TBI and Fludarabine Followed by Nonmyeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Postgrafting Immunosuppression for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial

NCT00027820 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT00027820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00027820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose TBI and Fludarabine Followed by Nonmyeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Postgrafting Immunosuppression for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2001
Completion date
September 5, 2004
Enrollment
106 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute myeloid leukemia in remission, childhood acute lymphoblastic leukemia in remission, childhood acute myeloid leukemia in remission, childhood myelodysplastic syndrome, childhood renal cell carcinoma, chronic myelomonocytic leukemia, clear cell renal cell carcinoma, de novo myelodysplastic syndrome, metastatic renal cell cancer, previously treated myelodysplastic syndrome, progression of multiple myeloma or plasma cell leukemia, recurrent adult acute lymphoblastic leukemia, recurrent adult acute myeloid leukemia, recurrent adult hodgkin lymphoma, recurrent adult lymphoblastic lymphoma, recurrent adult non-hodgkin lymphoma, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, recurrent childhood lymphoblastic lymphoma, recurrent childhood non-hodgkin lymphoma, refractory anemia, refractory anemia with ringed sideroblasts, refractory childhood hodgkin lymphoma, refractory chronic lymphocytic leukemia, renal medullary carcinoma, type 1 papillary renal cell carcinoma, type 2 papillary renal cell carcinoma, untreated adult acute lymphoblastic leukemia, untreated adult acute myeloid leukemia, untreated childhood acute lymphoblastic leukemia